
|Videos|June 1, 2021
Nevakar spins off ophthalmic-only company Vyluma
A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.
Advertisement
Navneet Puri, PhD, founder, chairman, and CEO of newly formed Vyluma discusses why Nevakar chose to make the move to ophthalmic-only pharma.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Dry eye an area of prime interest to ODs and MDs in 2025
2
Refractive surgery for myopia vs presbyopia: Tailoring the approach for the individual
3
2025 takes dry eye, presbyopia by storm
4
Systematic review finds driving negatively impacted by glaucomatous VF defects
5












































